News
ASX ETF provider Vanguard has revealed the next distribution (or dividend) for the Vanguard US Total Market Shares Index ETF ...
22h
Stocktwits on MSNGLP-1 Showdown In India: Eli Lilly’s Mounjaro Pen Approved Just Days After Novo’s Wegovy LaunchIndia’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...
Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...
Eli Lilly and Company (NYSE: LLY) is one of the best Fortune 500 stocks to buy according to billionaires. On June 20, Eli ...
Lincoln Financial Group has been in a holding pattern, posting a small return of 3.2% while floating around $33.15.
Hannah Mai, 37, from Coventry, gained 10st (6.3kg) because of a rare hormonal disorder - but credits one daily exercise for ...
Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...
Retired criminal defence barrister Allison Bailey is suing for £25,000 after she was 'expelled' from Palmerston Veterinary ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The country has the world’s third-highest number of obese people.
Discover how Ozempic is transforming America's eating, shopping, and dressing habits, with insights from Dr. Alexandra Sowa's book.
Eli Lilly Revenue Up on Demand for Mounjaro, Other Weight-Loss Meds The drug maker’s net income came in at $2.76 billion, or $3.06 a share, up from $2.24 billion, or $2.48 a share, in the prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results